(5S)-3-[6-[3-(2-fluorophenoxy)pyrrolidin-1-yl]-3-pyridinyl]-5-(hydroxymethyl)-1,3-oxazolidin-2-one
C19H20FN3O4 — CID 143639048
Data last refreshed: (MolForge compound catalog, from PubChem)
About (5S)-3-[6-[3-(2-fluorophenoxy)pyrrolidin-1-yl]-3-pyridinyl]-5-(hydroxymethyl)-1,3-oxazolidin-2-one
(5S)-3-[6-[3-(2-fluorophenoxy)pyrrolidin-1-yl]-3-pyridinyl]-5-(hydroxymethyl)-1,3-oxazolidin-2-one (PubChem CID 143639048) has the molecular formula C19H20FN3O4 and a molecular weight of 373.38 g/mol. Its IUPAC name is (5S)-3-[6-[3-(2-fluorophenoxy)pyrrolidin-1-yl]-3-pyridinyl]-5-(hydroxymethyl)-1,3-oxazolidin-2-one.
Molecular Properties
| Compound Name | (5S)-3-[6-[3-(2-fluorophenoxy)pyrrolidin-1-yl]-3-pyridinyl]-5-(hydroxymethyl)-1,3-oxazolidin-2-one |
|---|---|
| PubChem CID | 143639048 |
| Molecular Formula | C19H20FN3O4 |
| Molecular Weight | 373.38 g/mol |
| Exact Mass | 373.14 |
| IUPAC Name | (5S)-3-[6-[3-(2-fluorophenoxy)pyrrolidin-1-yl]-3-pyridinyl]-5-(hydroxymethyl)-1,3-oxazolidin-2-one |
| SMILES | O=C1O[C@H](CO)CN1c1ccc(N2CCC(Oc3ccccc3F)C2)nc1 |
| InChI | InChI=1S/C19H20FN3O4/c20-16-3-1-2-4-17(16)26-14-7-8-22(10-14)18-6-5-13(9-21-18)23-11-15(12-24)27-19(23)25/h1-6,9,14-15,24H,7-8,10-12H2/t14?,15-/m0/s1 |
| InChIKey | RUENYXCLAYUBAB-LOACHALJSA-N |
| XLogP | 2.20 |
| TPSA | 75.13 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 373.38 |
| LogP ≤ 5 | 2.20 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 143639048 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.